$ITCI
Intra-Cellular Therapies, Inc.

2023 Q1 Form 10-K Financial Statement

#000119312523055176 Filed on March 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q1
Revenue $95.31M $87.87M $35.00M
YoY Change 172.33% 242.29% 120.38%
Cost Of Revenue $6.751M $6.788M $3.155M
YoY Change 113.98% 167.45% 116.1%
Gross Profit $88.56M $81.08M $31.84M
YoY Change 178.12% 250.5% 120.81%
Gross Profit Margin 92.92% 92.27% 90.98%
Selling, General & Admin $98.92M $94.63M $75.46M
YoY Change 31.09% 18.77% 43.51%
% of Gross Profit 111.71% 116.71% 236.99%
Research & Development $38.02M $33.86M $29.04M
YoY Change 30.92% 14.95% 92.85%
% of Gross Profit 42.94% 41.76% 91.21%
Depreciation & Amortization $134.0K $143.0K $171.0K
YoY Change -21.64% -2.61% 31.54%
% of Gross Profit 0.15% 0.18% 0.54%
Operating Expenses $143.7M $135.3M $104.5M
YoY Change 37.51% 23.95% 54.5%
Operating Profit -$48.39M -$54.20M -$72.66M
YoY Change -33.4% -36.98% 36.53%
Interest Expense $4.349M $3.386M $548.0K
YoY Change 693.61% 1151.2% 14.17%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$44.04M -$44.03M -$72.11M
YoY Change -38.93% -48.65% 36.76%
Income Tax $10.00K $0.00 $5.000K
% Of Pretax Income
Net Earnings -$44.05M -$44.03M -$72.12M
YoY Change -38.92% -48.65% 36.74%
Net Earnings / Revenue -46.22% -50.1% -206.08%
Basic Earnings Per Share -$0.46 -$0.45 -$0.78
Diluted Earnings Per Share -$0.46 -$0.45 -$778.8K
COMMON SHARES
Basic Shares Outstanding 95.28M 94.71M 92.60M shares
Diluted Shares Outstanding 95.13M shares 92.60M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $538.7M $591.9M $771.8M
YoY Change -30.21% 43.55% 26.12%
Cash & Equivalents $75.73M $148.6M $129.3M
Short-Term Investments $463.0M $443.3M $642.6M
Other Short-Term Assets $57.50M $46.94M $35.77M
YoY Change 60.75% 74.88% 124.96%
Inventory $28.34M $23.92M $7.893M
Prepaid Expenses
Receivables $81.55M $75.19M $32.83M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $706.1M $738.0M $848.3M
YoY Change -16.77% 57.93% 30.7%
LONG-TERM ASSETS
Property, Plant & Equipment $1.779M $1.913M $20.15M
YoY Change -91.17% 6.81% -20.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $86.00K $86.00K $86.00K
YoY Change 0.0% 0.0% -14.0%
Total Long-Term Assets $16.06M $16.82M $20.24M
YoY Change -20.62% -25.7% -20.32%
TOTAL ASSETS
Total Short-Term Assets $706.1M $738.0M $848.3M
Total Long-Term Assets $16.06M $16.82M $20.24M
Total Assets $722.2M $754.8M $868.6M
YoY Change -16.86% 54.06% 28.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.441M $10.40M $11.65M
YoY Change -27.54% 19.61% 33.9%
Accrued Expenses $71.15M $72.84M $47.43M
YoY Change 50.02% 63.08% 52.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $79.59M $83.24M $59.07M
YoY Change 34.72% 56.0% 48.8%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $14.96M $15.47M $16.76M
YoY Change -10.71% -17.14% -25.86%
Total Long-Term Liabilities $14.96M $15.47M $16.76M
YoY Change -10.71% -17.14% -25.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $79.59M $83.24M $59.07M
Total Long-Term Liabilities $14.96M $15.47M $16.76M
Total Liabilities $94.55M $98.71M $75.83M
YoY Change 24.68% 37.04% 21.72%
SHAREHOLDERS EQUITY
Retained Earnings -$1.522B -$1.477B
YoY Change 20.98%
Common Stock $2.152B $2.138B
YoY Change 30.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $627.6M $656.1M $792.8M
YoY Change
Total Liabilities & Shareholders Equity $722.2M $754.8M $868.6M
YoY Change -16.86% 54.06% 28.77%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q1
OPERATING ACTIVITIES
Net Income -$44.05M -$44.03M -$72.12M
YoY Change -38.92% -48.65% 36.74%
Depreciation, Depletion And Amortization $134.0K $143.0K $171.0K
YoY Change -21.64% -2.61% 31.54%
Cash From Operating Activities -$60.07M -$39.19M -$82.85M
YoY Change -27.5% -46.45% 73.43%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$28.00K -$566.0K
YoY Change -100.0% 2158.06%
Acquisitions
YoY Change
Other Investing Activities -$16.46M $50.24M -$321.5M
YoY Change -94.88% -2.48% -376.48%
Cash From Investing Activities -$16.46M $50.26M -$322.0M
YoY Change -94.89% -2.42% -376.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.640M 2.187M 441.8M
YoY Change -99.18% -72.37% 30796.08%
NET CHANGE
Cash From Operating Activities -$60.07M -39.19M -82.85M
Cash From Investing Activities -$16.46M 50.26M -322.0M
Cash From Financing Activities $3.640M 2.187M 441.8M
Net Change In Cash -$72.89M 13.26M 36.93M
YoY Change -297.37% -196.34% -47.19%
FREE CASH FLOW
Cash From Operating Activities -$60.07M -$39.19M -$82.85M
Capital Expenditures $0.00 -$28.00K -$566.0K
Free Cash Flow -$60.07M -$39.16M -$82.28M
YoY Change -27.0% -46.48% 72.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0087
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001567514
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-36274
CY2022 dei Entity Registrant Name
EntityRegistrantName
Intra-Cellular Therapies, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-4742850
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
430 East 29th Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10016
CY2022 dei City Area Code
CityAreaCode
646
CY2022 dei Local Phone Number
LocalPhoneNumber
440-9333
CY2022 dei Security12b Title
Security12bTitle
Common Stock
CY2022 dei Trading Symbol
TradingSymbol
ITCI
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
5300000000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
95280003
CY2022 dei Auditor Firm
AuditorFirmId
42
CY2022 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2022 dei Auditor Location
AuditorLocation
Baltimore, Maryland
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148615000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
92365000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2407000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
443290000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
319968000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1750000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1400000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
75189000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20156000
CY2022Q4 us-gaap Inventory Net
InventoryNet
23920000
CY2021Q4 us-gaap Inventory Net
InventoryNet
7948000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
45193000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25444000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
737957000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
467281000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1913000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1791000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14824000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20764000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
86000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
86000
CY2022Q4 us-gaap Assets
Assets
754780000
CY2021Q4 us-gaap Assets
Assets
489922000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10395000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8691000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
19657000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
11073000
CY2022Q4 itci Accrued Customer Programs Current
AccruedCustomerProgramsCurrent
25621000
CY2021Q4 itci Accrued Customer Programs Current
AccruedCustomerProgramsCurrent
5964000
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
22996000
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
20897000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4567000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6732000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
83236000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
53357000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15474000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18675000
CY2022Q4 us-gaap Liabilities
Liabilities
98710000
CY2021Q4 us-gaap Liabilities
Liabilities
72032000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
94829794
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
94829794
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81886965
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81886965
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
8000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2137737000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1639476000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1477486000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1221230000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4190000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-364000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
656070000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
417890000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
754780000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
489922000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
250314000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83803000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22813000
CY2022 itci Costofproductsales
Costofproductsales
20443000
CY2021 itci Costofproductsales
Costofproductsales
8035000
CY2020 itci Costofproductsales
Costofproductsales
1895000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
358782000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
272611000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
186364000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
134715000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
88845000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
65782000
CY2022 us-gaap Operating Expenses
OperatingExpenses
513940000
CY2021 us-gaap Operating Expenses
OperatingExpenses
369491000
CY2020 us-gaap Operating Expenses
OperatingExpenses
254041000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-263626000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-285688000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-231228000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
7376000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
1568000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
4236000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-256250000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-284120000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-226992000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-256256000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-284126000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-227006000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.72
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.72
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.5
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.5
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.23
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.23
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94046670
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
94046670
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81253394
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81253394
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70364800
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70364800
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-256256000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-284126000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-227006000
CY2022 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-3826000
CY2021 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-845000
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
353000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-260082000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-284971000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-226653000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
195007000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
652712000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
11465000
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
214000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24115000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-227006000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
353000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
656860000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
11519000
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
179000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34303000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-284126000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-845000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
417890000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
433718000
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
21441000
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
90000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
43013000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-256256000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3826000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
656070000
CY2022 us-gaap Profit Loss
ProfitLoss
-256256000
CY2021 us-gaap Profit Loss
ProfitLoss
-284126000
CY2020 us-gaap Profit Loss
ProfitLoss
-227006000
CY2022 us-gaap Depreciation
Depreciation
656000
CY2021 us-gaap Depreciation
Depreciation
533000
CY2020 us-gaap Depreciation
Depreciation
528000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
43013000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
34303000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
24115000
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
90000
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
179000
CY2020 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
214000
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-447000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
4080000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
648000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
55033000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9391000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10765000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15972000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
892000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7056000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
19749000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11208000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7922000
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0
CY2021 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0
CY2020 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-265000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1704000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3189000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1923000
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
8584000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3177000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-8242000
CY2022 itci Increase Decrease In Accrued Customer Programs
IncreaseDecreaseInAccruedCustomerPrograms
-19657000
CY2021 itci Increase Decrease In Accrued Customer Programs
IncreaseDecreaseInAccruedCustomerPrograms
-2958000
CY2020 itci Increase Decrease In Accrued Customer Programs
IncreaseDecreaseInAccruedCustomerPrograms
-5435000
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2099000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5989000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3005000
CY2022 itci Increase Decrease In Operating Lease Liabilitites Current
IncreaseDecreaseInOperatingLeaseLiabilititesCurrent
574000
CY2021 itci Increase Decrease In Operating Lease Liabilitites Current
IncreaseDecreaseInOperatingLeaseLiabilititesCurrent
-175000
CY2020 itci Increase Decrease In Operating Lease Liabilitites Current
IncreaseDecreaseInOperatingLeaseLiabilititesCurrent
-73000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-270186000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-259544000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-230073000
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
759209000
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
224575000
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
755629000
CY2022 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
631614000
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
505244000
CY2020 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
275601000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
778000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
325000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
267000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-128373000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
280344000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-480295000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
433718000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
652712000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21441000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11519000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11465000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
455159000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11519000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
664177000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
56600000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32319000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-46191000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93765000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61446000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107637000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150365000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93765000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61446000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
6000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
6000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
2000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148615000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
92365000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60046000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1750000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1400000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1400000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150365000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93765000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61446000
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10952381
CY2022Q1 us-gaap Share Price
SharePrice
42
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although actual results could differ from those estimates, management does not believe that such differences would be material. </div></div>
CY2022 us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reclassifications </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certain amounts reported in prior periods have been reclassified to conform to current period financial statement presentation. These reclassifications have no material effect on previously reported financial position, cash flows, or results of operations. </div></div>
CY2022 itci Cash And Cash Equivalent Maximum Maturity Period
CashAndCashEquivalentMaximumMaturityPeriod
P3M
CY2022 itci Available For Sale Securities Maturity Period
AvailableForSaleSecuritiesMaturityPeriod
more than three months
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4099000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3057000
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments which potentially subject the Company to concentrations of credit risk consist of accounts receivable, net from customers and cash, cash equivalent and investments held at financial institutions. For the years ended December 31, 2022 and 2021, 97% and 96% of product sales were generated from three major industry wholesalers, respectively. </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Three individual customers accounted for approximately 39%, 30%, and 28% and 40%, 28%, and 28% of product sales for the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, the Company believes that these customers are of high credit quality. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash equivalents are held with major financial institutions in the United States. Certificates of deposit, cash and cash equivalents held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and, therefore, bear minimal risk. </div></div>
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022Q3 itci Percentage Of Investments Qualified For Investment Tax Credit
PercentageOfInvestmentsQualifiedForInvestmentTaxCredit
0.25
CY2022Q3 itci Percentage Of Investments Qualified For Investment Tax Credit
PercentageOfInvestmentsQualifiedForInvestmentTaxCredit
0.15
CY2022 itci Average Annual Adjusted Income
AverageAnnualAdjustedIncome
1000000000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 us-gaap Inventory Net
InventoryNet
23920000
CY2021Q4 us-gaap Inventory Net
InventoryNet
7948000
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
490419000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
21000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4211000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
486229000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
320333000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
20000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
385000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
319968000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
438300000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
49100000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
389200000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
263500000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
9500000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
254100000
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
12200000
CY2021Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
56500000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
17227000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2484000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2594000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.949
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y10M24D
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7137000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6359000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5224000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4568000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1913000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1791000
CY2022 us-gaap Depreciation
Depreciation
700000
CY2021 us-gaap Depreciation
Depreciation
500000
CY2020 us-gaap Depreciation
Depreciation
500000
CY2022Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14824000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20764000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4567000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6732000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15474000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18675000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
20041000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
25407000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
4719000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
5774000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
1612000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
2676000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
873000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2022 us-gaap Lease Cost
LeaseCost
7204000
CY2021 us-gaap Lease Cost
LeaseCost
8450000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y1M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0876
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0846
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.916
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.955
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0222
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
4741000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
3792000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
3907000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
3974000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
4022000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
5915000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
26351000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6310000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
20041000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4567000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15474000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
43013000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
34303000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
24115000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.787
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.887
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.894
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0129
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-223465000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-221216000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-155616000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-32785000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-62904000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-71376000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-256250000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-284120000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-226992000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
14000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-52789000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-53070000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-40049000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-52789000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-53070000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-40049000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0192
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.006
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0101
CY2022 itci Effective Income Tax Rate Reconciliation Subpart Finclusion
EffectiveIncomeTaxRateReconciliationSubpartFinclusion
-0.0338
CY2021 itci Effective Income Tax Rate Reconciliation Subpart Finclusion
EffectiveIncomeTaxRateReconciliationSubpartFinclusion
0
CY2020 itci Effective Income Tax Rate Reconciliation Subpart Finclusion
EffectiveIncomeTaxRateReconciliationSubpartFinclusion
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0269
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0463
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.066
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0017
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.0031
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0112
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0358
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0204
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0314
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.206
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.187
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1765
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
663200000
CY2022 itci Federal Net Operating Loss Carry Forward Expiration Period
FederalNetOperatingLossCarryForwardExpirationPeriod
2037
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
168606000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
137561000
CY2022Q4 itci Deferred Tax Assets Tax Deferred Expense Accrued Expenses
DeferredTaxAssetsTaxDeferredExpenseAccruedExpenses
9169000
CY2021Q4 itci Deferred Tax Assets Tax Deferred Expense Accrued Expenses
DeferredTaxAssetsTaxDeferredExpenseAccruedExpenses
2723000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
9321000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
9321000
CY2022Q4 itci Deferred Tax Assets Tax Deferred Expense Research And Development Expenses
DeferredTaxAssetsTaxDeferredExpenseResearchAndDevelopmentExpenses
13525000
CY2021Q4 itci Deferred Tax Assets Tax Deferred Expense Research And Development Expenses
DeferredTaxAssetsTaxDeferredExpenseResearchAndDevelopmentExpenses
0
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
17085000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
15947000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1466000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
93000
CY2022Q4 itci Deferredtaxassetstaxdeferredexpensereservesandaccrualscapitallease
Deferredtaxassetstaxdeferredexpensereservesandaccrualscapitallease
4980000
CY2021Q4 itci Deferredtaxassetstaxdeferredexpensereservesandaccrualscapitallease
Deferredtaxassetstaxdeferredexpensereservesandaccrualscapitallease
6178000
CY2022Q4 itci Deferredtaxliabilitiesrightofuseassetcapitallease
Deferredtaxliabilitiesrightofuseassetcapitallease
3684000
CY2021Q4 itci Deferredtaxliabilitiesrightofuseassetcapitallease
Deferredtaxliabilitiesrightofuseassetcapitallease
5049000
CY2022Q4 itci Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
154000
CY2021Q4 itci Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
201000
CY2022Q4 itci Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
220314000
CY2021Q4 itci Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
166573000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
220314000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
166573000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1700000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1700000
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2022 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2022 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3900000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3000000
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1800000
CY2022Q4 us-gaap Revenues
Revenues
87869000
CY2022Q3 us-gaap Revenues
Revenues
71870000
CY2022Q2 us-gaap Revenues
Revenues
55579000
CY2022Q1 us-gaap Revenues
Revenues
34996000
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
135281000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
127499000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
143502000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
107658000
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
3386000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2122000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1320000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
548000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-44026000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-53508000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-86603000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-72119000
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.92
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.92
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
CY2021Q4 us-gaap Revenues
Revenues
25671000
CY2021Q3 us-gaap Revenues
Revenues
22207000
CY2021Q2 us-gaap Revenues
Revenues
20047000
CY2021Q1 us-gaap Revenues
Revenues
15878000
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
111675000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
99531000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
89188000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
69097000
CY2021Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
270000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
393000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
421000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
484000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-24000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-85734000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-76908000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-68744000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-52740000
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.05
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.05
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.95
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.95
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65

Files In Submission

Name View Source Status
itci-20221231_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001193125-23-055176-index-headers.html Edgar Link pending
0001193125-23-055176-index.html Edgar Link pending
0001193125-23-055176.txt Edgar Link pending
0001193125-23-055176-xbrl.zip Edgar Link pending
d436875d10k.htm Edgar Link pending
d436875dex102.htm Edgar Link pending
d436875dex1032.htm Edgar Link pending
d436875dex211.htm Edgar Link pending
d436875dex231.htm Edgar Link pending
d436875dex311.htm Edgar Link pending
d436875dex312.htm Edgar Link pending
d436875dex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g436875g01a06.jpg Edgar Link pending
g436875page30.jpg Edgar Link pending
itci-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
itci-20221231_cal.xml Edgar Link unprocessable
itci-20221231_pre.xml Edgar Link unprocessable
itci-20221231_lab.xml Edgar Link unprocessable
d436875d10k_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending